Skip to main content
Rocket Doctor AI Inc. logo

Rocket Doctor AI Inc. — Investor Relations & Filings

Ticker · AIDR ISIN · CA7729241066 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 346 across all filing types
Latest filing 2024-09-17 Regulatory Filings
Country CA Canada
Listing CSE AIDR

About Rocket Doctor AI Inc.

https://www.rocketdoctor.ai/

Rocket Doctor AI Inc. is a healthcare technology company specializing in medical AI solutions designed to improve patient care accessibility and outcomes across the full patient journey. The company delivers physician-built, AI-powered tools, including healthcare APIs and a proprietary "AI brain" that powers scalable clinical and diagnostic solutions. Rocket Doctor AI operates an AI-enhanced digital health platform and marketplace, often characterized as a "Shopify for physicians," which facilitates virtual health services and empowers medical professionals. Core offerings also include AI-powered clinical training and assessment tools for medical learners, an AI-powered voice assistant for mental health and care support, and advanced AI-powered Clinical Decision Support systems. The company focuses on delivering high-quality, accessible healthcare solutions throughout North America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2024-09-17 English
News release - English.pdf
Transaction in Own Shares Classification · 95% confidence The document is a press release announcing that Treatment.com AI Inc. has entered into a consulting agreement to issue shares as payment for services. It details the terms of the agreement, the number of shares to be issued, and the share price. There is no financial report, earnings data, or regulatory filing referenced. The document is an announcement about a share issuance related to services, which fits the category of Transaction in Own Shares (POS). The document length is short (3464 characters), and it is not a report publication or certification. Therefore, the best classification is POS with high confidence.
2024-09-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a collaborative agreement between Treatment.com AI and the University of Edinburgh to work on a transformative project in long-term care services. It includes details about the partnership, project goals, and marketing agreement amendments. There is no financial data, regulatory filing references, or report attachments. The content is a corporate announcement about a strategic partnership and business development, not a financial report, regulatory filing, or shareholder meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2024-09-05 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2024-08-29 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release dated August 21, 2024, from Treatment.com AI Inc. It discusses the company's AI healthcare platform, recent industry events, and future plans. There are no financial statements, regulatory filings, or detailed financial data presented. The content focuses on company updates, product information, and forward-looking statements rather than financial results or governance changes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing or certification. The document is a general corporate announcement or update, which best fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2024-08-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release providing an update on recent market activity and confirming no undisclosed material changes in the company's operations. It references regulatory requests from the Canadian Investment Regulatory Organization (CIRO) and mentions investor relations campaigns. The document does not contain financial statements, detailed financial performance data, or management discussion of results. It is a short announcement focused on market activity and regulatory confirmation rather than a full report or detailed financial disclosure. Given its nature as a regulatory announcement and update without substantive financial data, it fits best under Regulatory Filings (RNS).
2024-08-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.